Objective: To examine the relative effects of high and low glycemic index (GI) carbohydrates, and monounsaturated fats on blood glucose and lipid metabolism in NIDDM subjects. Subjects: Fourteen male and seven female variably controlled NIDDM subjects recruited by advertisement. Setting: Free living outpatients. Research design: A repeated measures, within-subject design was used such that each subject consumed three diets: (a) a high-GI diet (53% CHO7 21% fat, 63 GI units (glucose 100)); (b) a low-GI diet (51% CHO 7 23% fat, 43 GI units); and (c) a high-mono high-GI diet (42% CHO735% fat, 59 GI units) in random order and cross-over fashion for four weeks. Approximately 45% energy was provided as key foods which differed in published GI values and speci®cally excluded legumes. Dietary ®bre intake was b 30 gad on each diet. At the end of each dietary intervention, we measured fasting plasma lipids, glucose, insulin, total glycated plasma protein, fructosamine, LDL and HDL particle size as well as 24 h urinary excretion of glucose and C-peptide. Results: HDL-cholesterol was higher on the low-GI and high-mono high-GI diets compared to the high-GI diet (P`0.05 for overall diet effect). There were no other signi®cant differences in metabolic control between diets, even when adjusted for BMI, glucose control or gender. Body weight and saturated fat intake remained stable between dietary interventions. Conclusion: High-mono high-GI and high-CHO, low-GI diets are superior to high-CHO, high-GI diets with respect to HDL metabolism but no effect was noted on glucose metabolism in variably controlled NIDDM subjects. Sponsorship: This study was funded by CSIRO Human Nutrition.
Introduction
NIDDM is associated with several lipid aberrations, namely, hypertriglyceridemia, elevated VLDL cholesterol and reduced HDL cholesterol and both hyperglycemia and this dyslipidemia are implicated in the development of diabetic complications (De Fronzo et al, 1992; Laakso, 1994) .
Dietary guidelines for people with NIDDM currently include a diet containing less than 10% from saturated fat, up to 10% energy from polyunsaturated fat, with the distribution of energy from monounsaturated fat and carbohydrate (CHO) dependent on treatment goals (American Diabetes Association, 1994) . The high-CHO diet has been shown to improve glycemic control (Brunzell et al, 1971; Anderson, 1977; Kiehm et al, 1976; Simpson et al, 1979) , lower plasma LDL cholesterol concentrations (O'Dea et al, 1989; Riccardi et al, 1984) and reduce insulin requirements (Anderson, 1977; Kiehm et al, 1976) . However, some studies have shown that high-CHO diets have hypoglycemic and hypolipidemic bene®ts only when they contain a large amount of dietary ®bre (O'Dea et al, 1989; Riccardi et al, 1984) and furthermore, other studies have shown that high-CHO diets low in ®bre result in increased plasma glucose and triacylglycerol, and decreased HDL concentrations (Reaven & Olefsky 1974; Brunzell et al, 1974; Ginsberg et al, 1976; Coulston et al, 1983; Sestoft et al, 1985; Coulston et al, 1989) which may persist for more than six weeks (Coulston et al, 1989) .
It is now well accepted that different foods containing an equal amount of CHO produce a wide range of glycemic responses (Crapo et al, 1977) and this discovery led to the development of the glycemic index (GI) method of ranking CHO-rich foods according to their relative glycemic impact (Jenkins et al, 1981; Foster-Powell & Brand-Miller, 1995) . This concept allows the comparison of different foods on the basis of their physiological effects rather than on their chemical composition.
A number of studies have shown that, compared to high-GI diets, chronic consumption of low-GI diets similar in ®bre and macronutrient composition, improve glycemic control and plasma lipid pro®les (Miller, 1994) . However, the clinical utility of the GI concept continues to be debated. Some studies have failed to show a differ-ence in overall postprandial glycemia when foods with different GI scores are incorporated into mixed meals (Coulston et al, 1987; Hollenbeck et al, 1988) . A number of methodological differences however, may account for the con¯icting results of different studies observed values for the GI of individual foods and mixed meals (Wolever et al, 1991; Wolever, 1997) . More recently, a review paper on glycaemic index in diabetes management (Dietitians Association of Australia, 1997) was released outlining the practical applications of the GI concept, but stresses that the macronutrient recommendations remain the primary consideration but that within the carbohydrate component of these recommendations, the GI is a useful tool. The glycemic index of the diet and its ®bre content has also been shown to predict the development of diabetes in men and women .
On the other hand, high-mono diets have been shown to improve glycemic control without causing detrimental changes in triacylglycerol and HDL cholesterol concentrations when compared to high-CHO, low-fat diets of similar ®bre content (Campbell et al, 1994; Garg et al, 1988; Rasmussen et al, 1993) . When the glycemic index could be estimated from the data these high-CHO diets have been generally high-GI and the carbohydrate in the high mono diet has also been high-GI. Whether high monounsaturated fat diets outperform low-GI high carbohydrate diets is unknown.
To our knowledge this current study is the ®rst to compare the short-term metabolic effects of a high-mono high-GI diet, and two high-CHO diets which contain carbohydrates that are either quickly (high-GI) or slowly (low-GI) digested. We hypothesised that both the high-CHO, low-GI and high-mono, high-GI diets would be more bene®cial for glycemic and lipid control in NIDDM patients than a high-CHO, high-GI diet. We also aimed to see if the recommended high mono diet was superior to a high CHO diet in which the GI was low, rather than high, as this is the main alternative dietary strategy and these two diets have not been previously tested in a formal study.
Materials and methods

Subjects
Twenty-eight volunteers (18 men and 10 women) with NIDDM but no history of renal disease were recruited by public advertisement. Volunteers had no history of retinopathy or vascular problems. Seven subjects dropped out of the study in the ®rst few weeks due to work commitments or illness unrelated to diabetes. These volunteers had very similar lipid and glucose levels to those who remained in the study. Sixteen subjects were treated with oral hypoglycemic agents (sulphonylureas and metformin) and ®ve by diet alone. None of the subjects were taking any drug known to affect lipid metabolism and no attempts were made to alter or interrupt therapeutic treatment during this study. The dose of drug was not altered during the study. Subject characteristics upon admission to the study are presented in Table 1 . Informed consent was obtained from all subjects and the study was approved by the Human Ethics Committee of the CSIRO Division of Human Nutrition.
Experimental Design
Free-living NIDDM subjects received three diets: (a) high-CHO, high-GI; (b) high-CHO, low-GI; and (c) high-mono high-GI for four weeks each in random order. There were no wash-out periods between dietary phases. Subjects were seen fortnightly by the same research dietitian who provided dietary instruction and assessment. At the end of each dietary period subjects came into the nutrition clinic on three consecutive mornings. They were required to refrain from alcohol consumption for 24 h prior to each visit, and to fast for 12 h overnight. At each visit, subjects were weighed and had blood drawn. On one of the three consecutive days subjects completed a 24 h urine collection. Throughout the 12 week study subjects continued their usual level of physical activity and body weight was maintained.
Diets
The GI of each diet was estimated by constructing menus consisting of foods differing in their published GI (FosterPowell et al, 1995) . The GI scores of seven daily menus were averaged to give a mean weekly GI score for each of the three diets. Each subject consumed: (a) a high-GI diet (53% CHO 7 21% fat, 63 GI units using glucose 100); (b) a low-GI diet (51% CHO 7 23% fat, 43 GI units); and (c) a high-mono high-GI diet (42% CHO 7 35% fat, 59 GI units) in random order and cross-over fashion.
The high-GI diet was based on wholemeal bread, high-GI ceral and high-GI fruits and vegetables. The low-GI diet was based on wholegrain bread, low-GI cereal and low-GI fruits and vegetables. Other carbohydrate sources were prohibited. Both high-CHO diets were low in fat and therefore subjects were given reduced-fat (60% fat) sunower oil margarine. In contrast, the high-mono high-GI diet was based on canola oil, canola margarine and almonds. Its carbohydrate sources were similar to that in the high-GI diet except for the breakfast cereal which was chosen for its contribution of monounsaturated fat. Tables 2  and 3 outline the dietary patterns for the high-CHO and high-mono high-GI diets and the speci®c study foods given to each subject, the latter providing approximately 45% of total energy requirements.
Before the study, and at fortnightly intervals, subjects received detailed dietary instructions on how to manipulate the GI of the two high-CHO diets, and the monounsaturated-fat content of the high-mono high-GI diet. As all meals were prepared and consumed at home, speci®c study foods, dietary guidelines and menus were provided to help subjects maintain compliance. The diets for all subjects were individualised to maintain constant energy intake.
The actual (mean AE s.e.m.) composition of the diets consumed by subjects throughout the study, and patient Values are means AE s.e.m. *P`0.01 for difference between men and women by unpaired t-test.
Metabolic responses to diet in NIDDM patients
ND Luscombe et al compliance was assessed from two day weighed food records plus a 24 h diet recall which were combined for analysis. These data were completed fortnightly by subjects throughout each dietary phase. Compliance was assessed as adequate if subjects reported consuming at least the appropriate amounts of all foods provided on 24 out of 28 d, and if the weighed food records andaor 24 h recalls were consistent with the planned macronutrient distributions. Energy and macronutrient intakes from the subjects' combined food records and dietary recalls were calculated using Dieta4 Nutrient Calculation' software (Xyris Software, Highgate Hill, QLD, Australia) based on data from the Australian food composition tables. Subjective assessment of the subjects' satisfaction with diets was obtained by a 7 point questionnaire with questions using either category or visual analogue rating scales. The questionnaires were completed while the subjects were in a fasted state during attendance at the Nutrition Clinic in the middle and end of each dietary intervention.
Biochemical analyses
Blood was collected by venipuncture into tubes containing Na 2 EDTA (®nal concentration 1 gaL K 2 EDTA). Plasma was isolated by low-speed centrifugation at 3000 rpm for 10 min (Beckman GS-6R Centrifuge, CA) and aliquots were frozen at 7 20 C. Urine volume was measured and aliquots were stored in airtight vials with no added preservatives at 7 20 C. Each biochemical analysis was done in one run at the end of this study.
Urinary glucose and plasma glucose, fructosamine, total cholesterol and triacylglycerol concentrations were measured on a Cobas-Bio centrifugal analyser (Roche Diagnostica, Basel, Switzerland) by using enzymatic kits (Hoffman-La Roche Diagnostica, Basel, Switzerland) and control sera. Plasma HDL cholesterol concentration was measured after precipitation of the LDL and VLDL lipoproteins with polyethylene glycol 6000 solution (Warnick et al, 1985) . The following modi®cation of the Friedewald equation (Friedewald et al, 1972) for molar concentrations was used to calculate LDL cholesterol : LDL (mmolaL) total cholesterol -triacylglycerola2.18 -high-density-lipoprotein cholesterol.
Total glycated plasma protein was measured using an automated af®nity HPLC system (ICI, LC 1100, ICI Instruments, Dingley, Australia), a 6 mm 6 1 cm Progel-TSK analytical column (Supelco, Bellfonte, PA, USA) packed with TSK boronate-5PW (Supelco, Bellfonte, PA, USA) as described (Cefalu et al, 1994) .
Lipoproteins were separated from 1 mL of plasma by a single centrifugation at a background density of 1.25 gamL in a 50.3 rotor (Beckman Instruments, Palo Alto, CA, USA) for 6 h at 120 000 rpm. Polyacrylamide gradient gel electrophoresis of LDL and HDL was performed by using 3 ± 13% and 3 ± 30% gradient gels, respectively (Gradipore LTD, Sydney, Australia) (Williams et al, 1990) . The gels were scanned with a laser densitometer (2202 ultrascan, LKB, Bromma, Sweden).
Fasting plasma insulin concentrations were measured in duplicate using a commercial radio-immunoassay kit (Pharmacia AB, Uppsala, Sweden). Urinary C-peptide was quantitatively measured with a commercial enzymelinked immunosorbent assay (DAKO Diagnostics, Cambridgeshire, UK).
Statistical analysis
Data is expressed as the mean AE s.e.m. Correlations, repeated measures ANOVA (for diet effects), covariate ANOVA, and two-tailed unpaired Student's t-tests (to compare differences between men and women), were performed with SPSS for windows statistical software (Chicago, USA). For the primary hypothesis, as well as for interaction effects and post hoc comparisons P values 0.05 were considered statistically signi®cant. Covariates used were gender, age, BMI, diet order and baseline lipid and glucose values, as well as energy in each diet phase. 
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Bonferroni correction was applied to post hoc multiple comparisons.
Results
Diets
The composition of the study diets as assessed from food records are presented in Table 4 . The low-GI diet's GI score (43 GI units) was 20 units lower than the high-GI diet's GI score (63 GI units) as calculated from the daily menus. Despite attempts to make all three diets isoenergetic, the high-mono high-GI diet provided 12% more energy than the high-GI diet (P`0.05 compared to the high-GI diet). A greater than two-fold increase in monounsaturated fat accounted for the difference in total fat between the high-mono high-GI and two high-CHO diets (P`0.001). The polyunsaturated fat content of the highmono high-GI diet also increased signi®cantly compared to both high-CHO diets (P`0.001). The three diets contained similar levels of saturated fat, ®bre and protein. Men differed from women only in total energy and ®bre intakes (P`0.001).
Questionnaires completed midway and at the end of each dietary intervention revealed all diets were well accepted and there were no signi®cant differences in the ratings of the three diets in overall score of acceptability, taste, satiety or variety. Whilst dietary compliance appeared excellent as assessed by the 24 h recall method, the weighed food record documentation of four subjects appeared incomplete. Statistical analyses therefore, were performed both with and without their data. Removing subjects with incomplete diet data from the analysis, however did not affect the results, nor did the order in which the subjects received the diets. (Table 5 ) No signi®cant differences in body weight were found among the dietary interventions despite the signi®cant 0.9 MJ de®cit reported in the high GI compared with the high MONO diet. Fasting plasma glucose concentrations and 24 h urinary glucose excretion did not change between the diets. Similarly, concentrations of total glycosylated plasma protein and fructosamine did not differ signi®cantly between dietary interventions. In addition, there were no signi®cant differences in plasma insulin or urinary Cpeptide excretion. Fasting plasma glucose was strongly correlated with 24 h urinary glucose excretion (r 0.78, P`0.001) and fructosamine (r 0.73, P`0.001).
Metabolic Variables
Plasma lipids and lipoproteins (Table 6 ) Overall, HDL-C was 6% higher on the low-GI (0.93 AE 0.04 mmolaL) and high-mono high-GI diets (0.93 AE 0.04 mmolaL) compared with the high GI diet (0.88 AE 0.04 mmolaL; P`0.05 for overall diet effect by repeated measures ANOVA). No other signi®cant differences were noted in plasma lipids. The subjects BMI, age, gender, degree of glycemic control, baseline triacylglycerol concentration or their type of therapeutic treatment did not affect the glucose, insulin or lipid results. When treatment order was taken into account adjusted plasma glucose was 8% lower on the low-GI diet compared with the high-GI diet but this was not statistically signi®cant (P b 0.1) but this difference may account for the HDL changes seen above.
Discussion
This current study was designed to evaluate the short-term effects of three alternative dietary treatments on glycemic control and lipid metabolism for people with NIDDM to de®ne the optimum diet for diabetes management. We believe this to be the ®rst study to have compared simultaneously the effects of high-and low-GI carbohydrates, and monounsaturated fats on plasma glucose and lipid concentrations in the same group of subjects. Dietary assessment Values as meansAE s.e.m. *Signi®cantly different to high-GI diet by repeated measures ANOVA with post hoc Bonferroni adjustment P`0.05. **Signi®cantly different to both high-GI and low-GI diets by repeated measures ANOVA with post hoc Bonferroni adjustment P`0.01. Metabolic responses to diet in NIDDM patients ND Luscombe et al and intervention was thorough and more intensive than conventional dietary counselling of free-living subjects with diabetes. We postulated that incorporating the GI concept in dietary planning should be equally effective using foods typical of those eaten by the study population, without the inclusion of legumes, provided that there was an adequate difference in GI units between diets. Hence, we believe that our results are more re¯ective of what occurs in a clinical setting than in a metabolic ward. None of the diets differed markedly with respect to their effects on glucose or lipid metabolism. However, although body weight was not statistically different during any of the dietary interventions, the small reported energy de®cit would amount to only a 0.8 kg difference over four weeks which would have been too low a difference to be detected, given the power of this experimental design. Nevertheless, the lower energy intake observed on the high-GI diet may have attenuated the differences between these diets, although statistical adjustment for the energy level on each diet did not in¯uence the results.
Only six published studies have compared high and low GI diets in type 2 diabetics with patient numbers varying from 6 ± 16. Therefore this study is the largest so far and the reduction in GI of 20 units is comparable to the other studies and greater than that seen in the study of Brand et al (1991) which was one of the more successful studies. A reduction in fasting glucose is usually not seen and the most common observation is a reduction in day long glucose or integrated measures of glucose level such as HbAlc, glycated albumin or fructosamine one of which was seen in ®ve of the six studies. One of the major reasons for the difference between the diets that did lower day long glucose levels and the diet used in our study was the presence of legumes in the apparently more effective diets, so the simple selection of lower GI foods such as pasta and whole grain bread may not provide the expected bene®t. Changes in blood cholesterol and triglyceride occurred in a minority of studies only and our study is compatible with the second largest study of Brand et al, 1991 in which no changes were seen.
The small increments in HDL cholesterol on a highmonounsaturated fat diet have been reported by some investigators (Garg et al, 1988; Coulston et al, 1989 ) although we did not observe a statistically signi®cant reduction in triacylglycerol concentration as they also described. However, a number of other studies, most of which were conducted in outpatients, have failed to show any changes in plasma lipids (Bonanome et al, 1991; Rasmussen et al, 1993; Walker et al, 1995) . The differences in HDL cholesterol on the three diets may relate to the small and non signi®cant differences in fasting glucose which were seen after adjustment for diet order as well as the increase in fat on the high-monounsaturated fat diet.
Although our resources did not permit assessing postprandial responses, previous studies have shown that highmono diets do have the ability to attenuate postprandial glucose responses (Campbell et al, 1994; Rasmussen et al, 1993) . This may re¯ect the lower carbohydrate content of these diets and the ability of fat to retard the gastric emptying rate.
Our ®ndings for the high-mono high-GI diet were consistent with one long-term study that showed a highmono diet did not alter glucose or lipid metabolism in freeliving NIDDM patients compared to a high-CHO, low-®bre diet (Bonanome et al, 1991) . In contrast, studies done under metabolic ward conditions with insulin using type 2 patients (Garg et al, 1988) , and studies using outpatients (Garg et al 1994 , Campbell et al, 1994 Walker et al, 1995) have found signi®cant reductions in concentrations of plasma glucose, insulin, triacylglycerol and VLDL cholesterol, and elevated HDL cholesterol concentrations after four weeks on a high-mono diet. A recent meta-analysis (Garg et al, 1998) has con®rmed that high monounsaturated fat diets reduce plasma triacylglycerol by 19% and modestly increase HDL cholesterol compared with high CHO diets. Fasting glucose levels were not different.
It should be noted that our subjects differed considerably in glycemic control, age, gender and BMI. In particular, some of our subjects had very poorly controlled NIDDM as evidenced by their fasting plasma glucose and 24 h urinary glucose excretion (nine volunteers had a fasting glucose greater than 10 mmolaL and a glucose excretion of b 50 mmolad). Glycemic control on the high-mono high-GI diet may not have improved because hepatic glucose production may have been high and uncontrolled in these subjects. The small decrease in carbohydrate load spread over the day may have been a relatively minor in¯uence on average blood glucose levels in comparison to the hepatic contribution. There was also a signi®cant correlation (r 0.54, P`0.01) between triacylglycerol concentration at screening and fasting plasma glucose, suggesting that those with higher plama triacylglycerol concentrations in our study population may have less well controlled NIDDM. This may also explain our failure to observe changes in plasma triacylglycerol with dietary modi®cation as there were no changes in overall glycemic control. Previous dietary trials, similar in design to this one, have examined more homogeneous and better controlled populations of NIDDM patients (Bonanome et al, 1991; Campbell et al, 1994; Walker et al, 1995) which may be a factor related to the observed improvements in glucose and lipid metabolism. Our results may suggest that when study populations differ widely in their glycemic or lipid control, the small effects of short term dietary change may be masked.
Conclusions
The aim of this study was to compare high-CHO with varying GI and high-mono high-GI diets under free-living conditions, using realistic dietary prescriptions centred on foods typically consumed in Australian society. Although energy balance was dif®cult to maintain on the high-CHO diets at higher energy levels, we found no evidence that the high-mono high-GI diet was conducive to weight gain in the short term. All diets were equally low in saturated fat and had similarly high dietary ®bre contents. In this context, both the low-GI and high-mono high-GI diet appear to be only marginally better dietary choices than the high-GI diet Ð and only in terms of plasma HDL cholesterol Ð in this heterogeneous population of NIDDM subjects. However, since most NIDDM subjects are overweight, it remains to be seen whether these diets differ to a greater extent in an energy de®cit situation.
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